Our journals offer ESMO members and the oncology community a globally visible platform to publish scientific studies, and a highly credible source of educational updates.
There are many good reasons to become an ESMO member. Find out why you should join Europe's leading medical oncology society
An annual Congress providing a comprehensive overview of all the practice-changing new data. Submit your abstract until 30 January 2019!
The ESMO-MCBS scale is a validated and reproducible tool to assess the magnitude of clinical benefit for cancer medicines.
ESMO Symposium on Signalling Pathways in Cancer 2019 in partnership with the EACR focuses on gene fusions from gene architecture evolution to cell addiction and therapeutic opportunities. ESMO and EACR Co-Chairs, Drs Andrea Sartore-Bianchi and Joan Seoane welcome all delegates from 26 to 27 April 2019 in Barcelona, Spain.
18 Jan 2019
New indication concerns the treatment of newly diagnosed Ph+ ALL in combination with chemotherapy
17 Jan 2019
Tackling legal and ethical challenges that big data brings
17 Jan 2019
Apply now for a travel grant to attend TAT 2019 – International Congress on Targeted Anticancer Therapies!
16 Jan 2019
Approval is based on results from the CELESTIAL trial
16 Jan 2019
The full version of the ESMO ASIA 2018 Abstract book is available online
16 Jan 2019
Online application available for the ESMO Advanced Course! Join us in Zurich!
Lugano, Switzerland
01 Feb
- 02 Feb
2019
Capetown, South Africa
15 Feb
- 17 Feb
2019
Valencia, Spain
22 Feb
- 22 Feb
2019
Paris, France
25 Feb
- 27 Feb
2019
Manchester, United Kingdom
06 Mar
- 08 Mar
2019
Lugano, Switzerland
08 Mar
- 10 Mar
2019
